Novartis Oncology Media

Cancer Research at Novartis Oncology

This content is intended for non-U.S. journalists. U.S. journalists, please visit the U.S. Media Room

Products
Research
- ASA404
- AUY922
- BEZ235
- BGT226
- BHQ880
- EVEROLIMUS
- Lucatumumab
- Midostaurin
- Panobinostat
- Patupilone
- RAF265
- SOM230
- TKI258
Disease States
Press Releases
Novartis Oncology

Research

SEARCH OUR WEBSITES

ABOUT NOVARTIS ONCOLOGY

Learn More About Novartis Oncology

We deliver a broad range of innovative therapies, cancer resources and oncology drugs to improve and extend the lives of cancer patients.

Learn more about Novartis Oncology

Disclaimer: This site is intended to provide information to audiences outside the United States. Please note that not all products listed within this site may be available in all countries. Also, prescribing information and indications for products may differ from country to country, so please consult your local Novartis company for local prescribing and any other information you may be interested in.

Oncology News is a current news service provided by Doctor's Guide®. Novartis accepts no responsibility for and makes no representations or warranties regarding the content of the information presented.